1
st
line NSCLC: IO Positive Ph3 trials to date
IO alone
KN-024
IO + CT
KN-189
Impower 150
IO + IO
CM 227
Stage III after
chemorads
PACIFIC
+
=
More and more patients will get IO before 2
nd
line